| Lifetime survival (n= 287)1 | Overall survival (n= 287)2 | Progression-free survival (n= 284) 2 | |||
---|---|---|---|---|---|---|
Censored | (0.12) | (0.12) | (0.23) | |||
Lifetime | 59.2 | 13.1 | 6.5 | |||
Gender | Â | Â | Â | Â | Â | Â |
   Male | 58.8 | (0.63) | 13.6 | (0.63) | 6.6 | (0.63) |
   Female | 61.1 | (0.37) | 12.1 | (0.37) | 6.4 | (0.37) |
Race | Â | Â | Â | Â | Â | Â |
   White | 59.7 | (0.77) | 13.1 | (0.77) | 6.8 | (0.77) |
   Other | 57.7 | (0.23) | 12.6 | (0.23) | 5.3 | (0.23) |
Therapy | Â | Â | Â | Â | Â | Â |
   CRnoT | 57.7 | (0.40) | 15.7 | (0.40) | 8.0 | (0.34) |
   R | 60.7 | (0.35) | 12.3 | (0.35) | 5.3 | (0.41) |
   CRT | 53.4 | (0.10) | 15.4 | (0.10) | 6.8 | (0.10) |
   Other | 64.8 | (0.08) | 14.2 | (0.08) | 7.9 | (0.08) |
   None | 70.5 | (0.07) | 2.9 | (0.07) | 1.4 | (0.07) |
ProgRec | Â | Â | Â | Â | Â | Â |
   Yes | 57.6 | (0.77) | 15.1 | (0.77) | - | (0.77) |
   No | 64.8 | (0.23) | 5.9 | (0.23) | - | (0.23) |